US 10548883
Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor
granted A61KA61K31/4155A61K31/4439
Quick answer
US patent 10548883 (Benzotriazole-derived α and β-unsaturated amide compound used as TGF-β RI inhibitor) held by Medshine Discovery Inc. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4155, A61K31/4439, A61P, A61P35/00